Most patients with SMA are affected by type 1 disease, or Werdnig-Hoffman disease, which can be particularly lethal. The median survival in patients with SMA type 1 is 7 months.
There is an inverse correlation between mortality and/or morbidity of SMA and age of onset. Early-onset disease confers the highest death rates. In patients with type 2 disease, length of survival is variable but is most often associated with respiratory complications.
Learn more about the prognosis associated with SMA.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Stephen L. Nelson. Fast Five Quiz: Spinal Muscular Atrophy - Medscape - Jan 14, 2021.
Comments